Antidepressants and menstruation disorders in women: A cross-sectional study in three centers

General Hospital Psychiatry

Volumn 34, Issue 5, 2012, Pages 529-533

  Uguz, Faruk ^a   Sahingoz, Mine ^a   Kose, Seyit Ali ^b   Ozbebit, Ozgur ^c   Sengul, Cem ^d   Selvi, Yavuz ^e   Sengul, Ceyhan Balci ^f   Ayhan, Medine Giynas ^a   Dagistanli, Adnan ^a   Askin, Rustem ^a  

^a NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

^b DUZCE UNIVERSITY   (Turkey)

^c Van Ipekyolu State Hospital   (Turkey)

^d PAMUKKALE UNIVERSITY   (Turkey)

^e YUZUNCU YIL UNIVERSITY   (Turkey)

^f DENIZLI STATE HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MILNACIPRAN; MIRTAZAPINE; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADULT; AMENORRHEA; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; GYNECOLOGIC DISEASE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MENOMETRORRHAGIA; MENSTRUAL FLOW DISORDER; MENSTRUAL IRREGULARITY; MENSTRUATION DISORDER; METRORRHAGIA; OLIGOMENORRHEA; PREVALENCE; UTERUS BLEEDING;

ADOLESCENT; ADULT; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS; CROSS-SECTIONAL STUDIES; CYCLOHEXANOLS; FEMALE; HUMANS; MENSTRUATION DISTURBANCES; MIANSERIN; PAROXETINE; QUALITATIVE RESEARCH; SERTRALINE; TURKEY; YOUNG ADULT;

EID: 84865367677     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2012.03.014     Document Type: Article

References (25)

1. Lendén M., Eriksson E. How does premenstrual dysphoric disorder relate to depression and anxiety disorders. Depress Anxiety 2003, 17:122-129.
2. Labad J., Menchón J.M., Alonso P., Segalàs C., Jiménez S., Vallejo J. Female reproductive cycle and obsessive-compulsive disorder. J Clin Psychiatry 2005, 66:428-435.
3. Vulink N.C., Denys D., Bus L., Westenberg H.G. Female hormones affect symptom severity in obsessive-compulsive disorder. Int Clin Psychopharmacol 2006, 21:171-175.
4. Lentz G.M. Abnormal uterine bleeding. Comprehensive gynecology 2007, 915-932. Mosby, Philadelphia (PA). 5th ed. V.L. Katz, G.M. Lentz, R.A. Lobo, D.M. Gershenson (Eds.).
5. Fritz M.A., Speroff L. Abnormal uterine bleeding. Clinical gynecologic endocrinology and infertility 1999, 236-238. Lippincott Williams & Wilkins, Baltimore. 6th ed. L. Speroff, R.H. Glass, N.G. Kase (Eds.).
6. London S.V. Abnormal uterine bleeding. Danforth's obstetrics and gynecology 2003, 643-651. Lippincott Williams & Wilkins, Philadelphia (PA). J.R. Scott, R.S. Gibbs, B.Y. Karlan, A.F. Haney (Eds.).
7. Newton Long W. Abnormal vaginal bleeding. Abnormal vaginal bleeding clinical methods: the history, physical, and laboratory examinations 1990, 810-811. Butterworths, Boston. 3rd ed. H.K. Walker, W.D. Hall, J.W. Hurst (Eds.).
8. Smith M., Robinson D. Sertraline and vaginal bleeding - a possible association. J Am Geriatr Soc 2002, 50:200-201.
9. Palmer T.R. Sertraline and vaginal bleeding - a possible association. J Am Geriatr Soc 2002, 51:279.
10. Linnebur S.A., Saseen J.J., Pace W.D. Venlafaxine-associated vaginal bleeding. Pharmacotherapy 2002, 22:652-655.
11. Meijer W.E., Heerdink E.R., Nolen W.A., Herings R.M., Leufkens H.G., Egberts A.C. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 2004, 164:2367-2370.
12. Andrade C., Sandarsh S., Chethan K.B., Nagesh K.S. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry 2010, 71:1565-1575.
13. Kent J.M. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Lancet 2000, 355:911-918.
14. Sánchez C., Hyttel J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 1999, 19:467-489.
15. Hergovich N., Aigner M., Eichler H.G., Entlicher J., Drucker C., Jilma B. Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther 2000, 68:435-442.
16. Flanagan R.J., Dunk L. Haematological toxicity of drugs used in psychiatry. Hum Psychopharmacol 2008, 23:27-41.
17. Mathussoodanan S., Parida S., Jimenez C. Hyperprolactinemia associated with psychotropics a review. Hum Psychopharmacol 2010, 25:281-297.
18. Prabhakar V.K., Davis J.R. Hyperprolactinemia. Best Pract Res Clin Obstet Gynecol 2008, 22:341-353.
19. Patel S.S., Ramigboye V. Hyperprolactinemia. J Obstet Gynecol 2007, 27:455-459.
20. Deecher D., Andree T.H., Sloan D., Schechter L.E. From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology 2008, 33:3-17.
21. Yu K.L., Rosenblum P.M., Peter R.E. In vitro release of gonadotropin-releasing hormone from the brain preoptic-anterior hypothalamic region and pituitary of female goldfish. Gen Comp Endocrinol 1991, 81:256-267.
22. Chang J.P., Van Goor F., Acharya S. Influences of norepinephrine, and adrenergic agonists and antagonists on gonadotropin secretion from dispersed pituitary cells of goldfish, Carassius auratus. Neuroendocrinology 1991, 54:202-210.
23. Rehavi M., Attali G., Gil-Ad I., Weizman A. Suppression of serum gonadal steroids in rats by chronic treatment with dopamine and serotonin reuptake inhibitors. Eur Neuropsychopharmacol 2000, 10:145-150.
24. Mennigen J.A., Marthyniuk C.J., Crump K., Xiong H., Zhao E., Popesku J., et al. Effects of fluoxetine on the reproductive axis of female goldfish (Carassius auratus). Physiol Genomics 2008, 35:273-282.
25. Livingstone M., Fraser I.S. Mechanisms of abnormal uterine bleeding. Hum Reprod Update 2002, 8:60-67.